Stockscreener 앱 받기
50.24
2.10%
-1.08
시간 외 거래:
49.27
-0.97
-1.93%
전일 마감가:
$51.32
열려 있는:
$51.04
하루 거래량:
221.87K
Relative Volume:
0.46
시가총액:
$3.21B
수익:
$112.53M
순이익/손실:
$-258.91M
주가수익비율:
-11.60
EPS:
-4.33
순현금흐름:
$-124.42M
1주 성능:
-2.71%
1개월 성능:
-12.72%
6개월 성능:
+1.25%
1년 성능:
+22.63%
1일 변동 폭
$50.13
$52.00
1주일 범위
$47.86
$52.35
52주 변동 폭
$35.17
$68.58
Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile
명칭
Rhythm Pharmaceuticals Inc
전화
857-264-4280
주소
222 BERKELEY STREET, BOSTON, MA
RYTM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RYTM
Rhythm Pharmaceuticals Inc
|
50.24 | 3.21B | 112.53M | -258.91M | -124.42M | -4.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 130.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 75.53B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.72B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 26.76B | 3.32B | -860.46M | -1.04B | -8.32 |
Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-05 | 재개 | Stifel | Buy |
| 2025-01-02 | 개시 | Jefferies | Buy |
| 2024-12-20 | 개시 | Oppenheimer | Outperform |
| 2024-10-21 | 개시 | Guggenheim | Buy |
| 2024-09-18 | 개시 | H.C. Wainwright | Buy |
| 2024-09-17 | 개시 | JMP Securities | Mkt Outperform |
| 2024-05-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-08-01 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-01-18 | 재개 | Canaccord Genuity | Buy |
| 2022-08-08 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-08-05 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-06-17 | 재확인 | Needham | Buy |
| 2022-03-02 | 재개 | Stifel | Buy |
| 2022-02-17 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2021-12-08 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-14 | 재개 | Goldman | Neutral |
| 2021-08-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-08-04 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-30 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-01-08 | 개시 | Goldman | Sell |
| 2019-07-12 | 업그레이드 | Stifel | Hold → Buy |
| 2019-07-08 | 개시 | Canaccord Genuity | Buy |
| 2019-03-13 | 개시 | Ladenburg Thalmann | Buy |
| 2018-09-07 | 재개 | Morgan Stanley | Overweight |
| 2018-06-25 | 재확인 | Needham | Buy |
| 2018-06-15 | 재확인 | Needham | Buy |
| 2017-10-30 | 개시 | BofA/Merrill | Buy |
| 2017-10-30 | 개시 | Needham | Buy |
모두보기
Rhythm Pharmaceuticals Inc 주식(RYTM)의 최신 뉴스
How To Trade (RYTM) - Stock Traders Daily
SBI Securities Co. Ltd. Invests $37,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Stifel maintains Buy on Rhythm Pharmaceuticals, $78 target By Investing.com - Investing.com Canada
Reviewing Wave Life Sciences (NASDAQ:WVE) & Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World
Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns Overweight Rating from Morgan Stanley - Defense World
Assessing Rhythm Pharmaceuticals: Insights From 10 Financial Analysts - Benzinga
Promising Outlook for Rhythm Pharmaceuticals: Buy Rating Backed by Positive Phase 3 Study Expectations and Market Potential - TipRanks
Stifel Nicolaus Begins Coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World
Analysts Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) PT at $68.27 - Defense World
Citizens JMP maintains Rhythm Pharma Outperform, $81 target By Investing.com - Investing.com South Africa
HC Wainwright Brokers Raise Earnings Estimates for RYTM - Defense World
Citizens JMP maintains Rhythm Pharma Outperform, $81 target - Investing.com India
Principal Financial Group Inc. Purchases 4,298 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Brokers Issue Forecasts for RYTM FY2026 Earnings - Defense World
Promising Market Potential for Rhythm Pharmaceuticals’ Setmelanotide in Treating Hypothalamic Obesity - TipRanks
Stifel raises Rhythm Pharmaceuticals stock to Buy with $78 target By Investing.com - Investing.com Canada
US High Growth Tech Stocks to Watch in March 2025 - Yahoo Finance
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates - MSN
Y Intercept Hong Kong Ltd Invests $328,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
HC Wainwright Issues Positive Forecast for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price - Defense World
Rhythm Pharmaceuticals Faces Financial Risks Due to Convertible Preferred Stock Prioritization - MSN
Rhythm Pharmaceuticals stock target raised to $70 at H.C. Wainwright - Investing.com India
Learn to Evaluate (RYTM) using the Charts - Stock Traders Daily
Decoding Rhythm Pharmaceuticals Inc (RYTM): A Strategic SWOT Ins - GuruFocus.com
Needham & Company LLC Reaffirms “Buy” Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World
Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
Rhythm Pharmaceuticals (NASDAQ:RYTM) Posts Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $81.00 - MarketBeat
Rhythm Pharmaceuticals sets annual meeting for June 24 By Investing.com - Investing.com South Africa
Rhythm Pharmaceuticals sets annual meeting for June 24 - Investing.com
Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns Buy Rating from Needham & Company LLC - MarketBeat
RHYTHM PHARMACEUTICALS, INC. SEC 10-K Report - TradingView
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Purchased by Rhumbline Advisers - Defense World
Rhythm Pharmaceuticals’ Earnings Call Highlights Growth and Challenges - TipRanks
Citizens JMP raises Rhythm Pharma stock target to $81 By Investing.com - Investing.com Canada
State of New Jersey Common Pension Fund D Makes New Investment in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2024 Earnings Call Transcript - Insider Monkey
Canaccord lifts Rhythm Pharma stock target to $81, keeps Buy rating By Investing.com - Investing.com South Africa
Rhythm Pharmaceuticals: Strong Buy Rating Backed by IMCIVREE’s Growth and Promising Pipeline Developments - TipRanks
Canaccord lifts Rhythm Pharma stock target to $81, keeps Buy rating - Investing.com UK
We Think Rhythm Pharmaceuticals (NASDAQ:RYTM) Can Afford To Drive Business Growth - Yahoo Finance
Rhythm Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highligh - GuruFocus.com
Rhythm Pharmaceuticals Reports Strong 2024 Growth and Strategic Advances - TipRanks
Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Rhythm Pharmaceuticals: Strong Commercial Execution and Promising Pipeline Drive Buy Rating - TipRanks
Earnings call transcript: Rhythm Pharmaceuticals Q4 2024 beats earnings forecast - Investing.com
Rhythm Pharmaceuticals Q4 Loss Widens, Revenue Increases -February 26, 2025 at 07:32 am EST - Marketscreener.com
Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q4 Revenue $41.8M, vs. FactSet Est of $38.5M - Marketscreener.com
Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q4 Net Loss $0.72 a Share, vs. FactSet Est of $0.69 Loss - Marketscreener.com
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update - TradingView
Rhythm Pharmaceuticals Inc (RYTM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rhythm Pharmaceuticals Inc 주식 (RYTM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shulman Joseph | Chief Technical Officer |
Feb 19 '25 |
Sale |
57.22 |
1,228 |
70,266 |
8,509 |
| Meeker David P | President and CEO |
Feb 19 '25 |
Sale |
57.22 |
9,896 |
566,249 |
201,281 |
| Lee Jennifer Kayden | EVP, Head of North America |
Feb 19 '25 |
Sale |
57.22 |
2,035 |
116,443 |
5,858 |
| German Christopher Paul | Corporate Controller & CAO |
Feb 19 '25 |
Sale |
57.22 |
635 |
36,335 |
2,070 |
| Cramer Pamela J. | Chief Human Resources Officer |
Feb 19 '25 |
Sale |
57.22 |
982 |
56,190 |
19,209 |
| Smith Hunter C | Chief Financial Officer |
Feb 12 '25 |
Sale |
56.39 |
751 |
42,347 |
105,544 |
| Shulman Joseph | Chief Technical Officer |
Feb 12 '25 |
Sale |
56.40 |
469 |
26,452 |
5,612 |
| Lee Jennifer Kayden | EVP, Head of North America |
Feb 12 '25 |
Sale |
56.39 |
1,815 |
102,348 |
3,598 |
| Lee Jennifer Kayden | EVP, Head of North America |
Feb 13 '25 |
Sale |
58.00 |
1,205 |
69,890 |
2,393 |
0.55%
1.89%
자본화:
|
볼륨(24시간):